Advertisement

Topics

Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia

2014-10-29 22:25:40 | BioPortfolio

Published on BioPortfolio: 2014-10-29T22:25:40-0400

Clinical Trials [579 Associated Clinical Trials listed on BioPortfolio]

Home Screening for Chlamydia Surveillance

This is a randomized controlled trial to determine whether a home screening test for chlamydia and gonorrhea will lead to increased use of screening tests and increased detection of sexual...

Check it: A New Approach to Controlling Chlamydia Transmission in Young People

This study, named "Check it," is a bundled program for African American (AA) men ages 15-24 that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects wh...

Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

This is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection. This study ...

STD Testing in Outpatient Practices

National guidelines have recommended routine STD screening (chlamydia and gonorrhea) for sexually active young women under the age of 25. Despite these recommendations, many young women ar...

Transmission of Genital and Extra-genital Chlamydia Trachomatis Infections in Women

Multicenter prospective cohort study in Chlamydia trachomatis positive women after regular treatment to understand the transmission of anorectal CT infections.

PubMed Articles [3818 Associated PubMed Articles listed on BioPortfolio]

We need to consider collateral damage to resistomes when we decide how frequently to screen for chlamydia/gonorrhoea in PrEP cohorts.

Numerous PrEP guidelines recommend 3 monthly screening for gonorrhoea and chlamydia. To quantify the risk of antimicrobial resistance this may induce, we conducted a literature review of the incidence...

Chlamydia screening, population prevalence, and the principles of screening for disease.

Diversity in the T cell response to Chlamydia-sum are better than one.

Chlamydia trachomatis is responsible for an increasing number of sexually transmitted infections in the United States and is a common cause of serious pathology in the female reproductive tract (FRT)....

High prevalence of sexual Chlamydia trachomatis infection in young women from Marajó Island, in the Brazilian Amazon.

Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) in the world. Approximately 80% of infected women are asymptomatic, although this infection can lead to serio...

Evaluating the Impact of Housing Status on Gonorrhea and Chlamydia Screening in an HIV Primary Care Setting.

Gonorrhea and chlamydia (GC/CT) testing falls below recommended rates for people living with HIV (PLWH) in routine care. Despite evidence that homelessness and unstable housing (HUH) negatively impact...

Medical and Biotech [MESH] Definitions

Species of CHLAMYDIA causing pneumonitis in mice and hamsters. These isolates formerly belonged to CHLAMYDIA TRACHOMATIS.

A genus of the family CHLAMYDIACEAE whose species cause a variety of diseases in vertebrates including humans, mice, and swine. Chlamydia species are gram-negative and produce glycogen. The type species is CHLAMYDIA TRACHOMATIS.

The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.

Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.

Infections with bacteria of the genus CHLAMYDIA.

More From BioPortfolio on "Leveraging Technology as a Clinician Extender to Screen Culturally Diverse Young Women for Chlamydia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial